STANDARDIZATION OF INCLUSION COMPLEX OF DISULFIRAM WITH HYDROXYPROPYL-β-CYCLODEXTRIN FOR USE AS PHARMACEUTICAL SUBSTANCES

STANDARDIZATION OF INCLUSION COMPLEX OF DISULFIRAM WITH HYDROXYPROPYL-β-CYCLODEXTRIN FOR USE AS PHARMACEUTICAL SUBSTANCES

The State Pharmacopoeia XIII sets out the main principles of quality of pharmaceutical substances listed parametrs that should be included in the regulatory documents, given the characteristics of these indicators and recommendations for their regulation. Input quality control performance and valuat...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. A. Kedik, A. V. Panov, V. S. Tyukova
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	standardization quality control pharmaceutical substances inclusion complex disulfiram hydroxypropyl-β-cyclodextrin
Online Access:	https://www.pharmjournal.ru/jour/article/view/91
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Structure of inclusion complex of disulfiram with hydroxypropyl-β-cyclodextrin
by: V. S. Tyukova, et al.
Published: (2015-10-01)

Influence de l’hydroxypropyl-β-Cyclodextrine et de l’hydroxypropyl-γ-Cyclodextrine sur la solubilité aqueuse de l’acide ellagique
by: Isaie Nyamba, et al.
Published: (2024-12-01)

Formulation of Caffeine–Hydroxypropyl-β-Cyclodextrin Complex in Hydrogel for Skin Treatment
by: Lyubomira Radeva, et al.
Published: (2025-04-01)

Aerosol of Enoximone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex, Biopharmaceutical Evidence for ARDS Applicability
by: Chiara Migone, et al.
Published: (2024-09-01)

CYCLODEXTRINS AND THEIR APPLICATION IN PHARMACEUTICAL INDUSTRY (REVIEW)
by: S. A. Kedik, et al.
Published: (2019-01-01)

Enhancing the Drug Release and Physicochemical Properties of Rivaroxaban via Cyclodextrin Complexation: A Comprehensive Analytical Approach
by: Cristina Solomon, et al.
Published: (2025-05-01)

Optimizing ibrutinib bioavailability: Formulation and assessment of hydroxypropyl-β-cyclodextrin-based nanosponge delivery systems
by: Sunitha Sampathi, et al.
Published: (2025-01-01)

Optimization and preparation of in-situ mucoadhesive gel of azithromycin hydroxypropyl-β-cyclodextrin inclusion complex against upper respiratory tract infections
by: Jitu Halder, et al.
Published: (2025-04-01)

Development of Low-Dose Disulfiram Rectal Suppository Intended for Application in Post-Treatment Lyme Disease Syndrome
by: Beáta-Mária Benkő, et al.
Published: (2025-06-01)

Improved Bioavailability of Stilbenes from <i>Cajanus cajan</i> (L.) Millsp. Leaves Achieved by Hydroxypropyl-<i>β</i>-Cyclodextrin Inclusion: Preparation, Characterization and Pharmacokinetic Assessment
by: Yingya Qiu, et al.
Published: (2025-06-01)

Disulfiram-induced polyneurophaty
by: Vujisić Slavica, et al.
Published: (2012-01-01)

A Zinc Oxide Interconnected Hydroxypropyl-Beta-Cyclodextrin/rGO Nanocomposite as an Electrocatalyst for Melatonin Detection: An Ultra-Sensitive Electrochemical Sensor
by: Kuo-Yuan Hwa, et al.
Published: (2025-05-01)

PEG-PLGA core–shell nanoparticles for the controlled delivery of picoplatin–hydroxypropyl β-cyclodextrin inclusion complex in triple-negative breast cancer: In vitro and in vivo study
by: Nafie Mohamed S., et al.
Published: (2024-12-01)

Cyclodextrin-based polyrotaxanes: Cellular uptake enhancement effect of different functionality types
by: David Gintsburg, et al.
Published: (2025-09-01)

Ultrasonic investigations of inclusion complexes of cyclodextrins with amphiphilic substances - further results and conclusions
by: A. Balcerzak
Published: (2004-01-01)

Evaluation of orally disintegrating films containing ferulic acid inclusion complexes: Physical characteristics and release kinetics
by: Junli Lv, et al.
Published: (2025-06-01)

Anti-atherosclerotic effect of lipid/cholesterol-cyclodextrin inclusion complexes similar to free cyclodextrins in ApoE-/- mice fed a high-fat diet
by: Yuanfang Li, et al.
Published: (2025-06-01)

PREPARATION OF NANOCOMPFEXES OF CURCUMINOIDS WITH CYCFODEXTRINS AND CHARACTERISTICS OF ITS STRUCTURAL AND FUNCTIONAL PROPERTIES
by: M. A. Kapustin, et al.
Published: (2022-08-01)

Standardization of the Pharmaceutical Substance of the Drug LCS-1208
by: E. V. Ignateva, et al.
Published: (2021-08-01)

Sudden Unexpected Death and Alcohol Addiction: Case Report on Disulfiram Use
by: Gabija Kondratavičiūtė, et al.
Published: (2025-02-01)

Pharmaceutical Substances. Requirements of the State Pharmacopoeia for Their Standardization
by: E. I. Sakanyan, et al.
Published: (2020-05-01)

Disulfiram inhibits bacterial growth by inducing zinc-dependent reactive oxygen species
by: Qinyu Luo, et al.
Published: (2025-07-01)

STANDARDIZATION OF CATIONIC DERIVATIVE OF BAKTERIOPURPURINIMID AS PHARMACEUTICAL SUBSTANCE FOR ANTIMICROBIAL PHOTODYNAMIC THERAPYA
by: A. M. Frolova, et al.
Published: (2019-01-01)

Hydroxypropyl Methylcellulose—A Key Excipient in Pharmaceutical Drug Delivery Systems
by: Robert-Alexandru Vlad, et al.
Published: (2025-06-01)

Electrospun Nanofibers Incorporated with HPγCD Inclusion Complex for Improved Water Solubility and Activity of Hydrophobic Fungicides Pyrimethanil
by: Shuang Gao, et al.
Published: (2025-03-01)

Patent-Based Technological Overview of Propolis–Cyclodextrin Inclusion Complexes with Pharmaceutical Potential
by: Salvana Costa, et al.
Published: (2025-07-01)

Strategies to Stabilize Dalbavancin in Aqueous Solutions; Section-2: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Acetate Buffer with and Without Divalent Metal Ions
by: Sardar M. Jakaria, et al.
Published: (2024-11-01)

Formulation and Characterization of Bilastine – Ternary Cyclodextrin Inclusion Complex
by: Eman B. H. Al-Khedairy, et al.
Published: (2025-03-01)

Effects of 2-Hydroxypropyl-β-Cyclodextrin on the Antioxidant Efficiency of Some Gallic Acid Derivatives in Soybean Oil-in-Water Emulsions
by: Tamara Martínez-Senra, et al.
Published: (2025-07-01)

Heterogeneous hydroxypropylation for the preparation of hydroxypropyl carrageenan and its application in Plant-Based hard capsules
by: Zi-Yun Zhou, et al.
Published: (2025-06-01)

Investigation of the Influence of Formulation Method on Technological Parameters of Gramicidin S and β-cyclodextrin Inclusion Complexes
by: A. A. Drannikov, et al.
Published: (2022-05-01)

Disulfiram-loaded nanovesicles hydrogel promotes healing of diabetic wound
by: Xingzi Sun, et al.
Published: (2024-11-01)

PEGylated Liposomes of Disulfiram and Paclitaxel: A Promising Chemotherapeutic Combination Against Chemoresistant Breast Cancer
by: Ammar Said Suliman, et al.
Published: (2025-03-01)

Exploring disulfiram mechanisms in renal fibrosis: insights from biological data and computational approaches
by: Vishal S. Patil, et al.
Published: (2025-03-01)

CHARACTERIZATION OF RUTIN-CYCLODEXTRIN INCLUSION COMPOUNDS
by: Andreia Corciovă, et al.
Published: (2011-12-01)

Comparative Evaluation of <i>β</i>-Cyclodextrin Inclusion Complexes with Eugenol, Eucalyptol, and Clove Essential Oil: Characterisation and Antimicrobial Activity Assessment for Pharmaceutical Applications
by: Alina Ionela Stancu, et al.
Published: (2025-06-01)

Polymer-Free Electrospinning of β-Cyclodextrin–Oligolactide for Magnolol and Honokiol Pharmaceutical Formulations
by: Diana-Andreea Blaj, et al.
Published: (2025-01-01)

Pediatric Orally Disintegrating Tablets (ODTs) with Enhanced Palatability Based on Propranolol HCl Coground with Hydroxypropyl-β-Cyclodextrin
by: Marzia Cirri, et al.
Published: (2024-10-01)

Disulfiram and cancer immunotherapy: Advanced nano-delivery systems and potential therapeutic strategies
by: Di Huang, et al.
Published: (2024-12-01)

Preparation and characterization of edible films from gelatin and hydroxypropyl methyl cellulose/sodium carboxymethyl cellulose
by: Jingjing Du, et al.
Published: (2025-01-01)